Part II covers advertising placed in professional journals aimed at healthcare professionals — that is, in print. Conference program booklets, company-published periodicals, and even cases where such material is later reposted to the Web all fall within the discipline described here. Where Part I governed "the material itself" through the product information summary, Part II governs "a printed page placed in public view as an advertisement." The guide's organizing idea — that media with different characters require different conventions — applies here just as plainly.
The core of Part II is continuous with Part I. It does not step a single pace beyond the scope of approval. It treats data honestly. It always carries the information that must not be dropped. Nothing relaxes simply because this is advertising. If anything, the narrower the page, the more the quality of judgment is tested in deciding what to cut and what to keep.
01Why journal advertising stands as its own part
A product information summary assumes that a healthcare professional actively requests it and reads it with deliberation. A journal advertisement is not like that. It enters the eye in the motion of a turning page, in the gaps between following academic papers. When the reader's posture differs, the conventions demanded of the writer differ too. The guide made Part II independent precisely because it accounts for this difference in how the material is received.
The foreword positioned the product information summary and similar materials as a complement to the package insert. The single word "complement" carries the meaning that no expression may exceed the original — the approved content. Journal advertising is no exception. If anything, because the advertising format has the power to form an impression in an instant, the danger of straying beyond the scope of approval is higher. That is exactly why a separate chapter is set out, lining up the safeguards specific to print advertising.
02Three types by content carried
Part II broadly divides advertising into three types according to what the page carries. Even under the single phrase "journal advertising," the breadth of information that may be shown differs entirely.
| Type | What may be carried | Character |
|---|---|---|
| Ordinary advertising | With advertising DI, including features, data, and catchphrases | The richest in information; it condenses something close to the depth of a product information summary onto a page |
| Product-name advertising | Name, therapeutic class name, regulatory category, whether listed in the drug price standard, and the marketing authorization holder's name only | An advertisement to make the product name remembered; it carries no efficacy or safety information at all |
| Editorial-style advertising | Informs broadly in the guise of an article or information (including tie-up articles) | If it touches on efficacy or safety, it must carry every mandatory item of ordinary advertising |
This three-way split has a purpose. The more information increases, the more room there is to create misunderstanding. So ordinary advertising, rich in information, bears the most mandatory entries, while product-name advertising, which carries almost no information, finds its discipline in "carrying none." Editorial-style advertising, wearing the face of an article, makes its key point the device that does not hide that it is advertising — the clear naming of the providing company. The details of each are developed in the child pages.
Ordinary advertising — not dropping the mandatory on a narrow page
In ordinary advertising, the following become mandatory: the name (brand and generic), therapeutic class name, regulatory category, indications (including related precautions), dosage and administration (likewise), precautionary information including warnings and contraindications, whether listed in the drug price standard, the marketing authorization holder's name, where applicable notes on insurance coverage and approval conditions, and the date of preparation. Text is six points or larger; warnings and contraindications are made conspicuous in gothic typeface at eight points or larger.
A narrow page is no excuse to cut the mandatory. The opposite, rather. The constraint of space confronts the writer with the priority of "what to place first." The Part I cover philosophy — placing the most important safety information in the first field of view — appears here as the design of a limited page. That reference information, head-to-head comparison trials, and case presentations are not carried in ordinary advertising is likewise a line drawn to avoid creating misunderstanding on a cramped page.
Product-name advertising — the discipline of "not carrying"
Product-name advertising is advertising centered on the product name. It carries neither indications nor dosage, nor any catchphrase that suggests efficacy or safety. Product logos and dosage-form photographs may be used, but combining them to imply efficacy or dosage is not permitted. At first glance it looks confining, but it is a type built on the resolve that "if no information is carried, no misunderstanding arises." For that very reason, provisions line up to close the loopholes — hinting at efficacy through photographs or figures.
Editorial-style advertising — not hiding that it is advertising
Because editorial-style advertising takes the form of an article or information, the reader finds it hard to notice it is advertising. So the providing company's name must be clearly written on the article page. Even in the guise of a roundtable or interview, data provided by a physician but not published in a paper, or data presented at a conference, are not carried. Impressions or sentiments of treatment experience avoid assertion and make no emphasis or guarantee. Even in the form of a statement, one may not suggest or recommend efficacy beyond approval. The loophole of "borrowing someone's mouth to step beyond the frame of approval" is one the guide clearly closes.
03How the discipline of science works on the page
The scientific conventions the foreword set out — the hierarchy of evidence, the difference in weight between pre-specified and post-hoc, that a significant difference is not clinical significance itself, the asymmetric duty to disclose safety even when unfavorable — operate consistently in journal advertising too.
Take significance testing of safety. A way of showing that places a significance test demonstrating no difference from placebo so as to create the impression that "adverse reactions are few" is not permitted in ordinary advertising. This is an expression of the design principle that closes off "true but misleading." Even if the test figure itself is fact, if the way it is placed forms a false image in the reader's mind, it is treated the same as falsehood.
Same data, different page, different treatment. In the features column of a product information summary, the comparator's adverse reactions are not written, yet in the clinical results column the comparator's event names and case counts are written — Part I carried such column-by-column asymmetry. The three types of Part II share the same structure. When the type differs, what may be carried differs. To bring something in without regard to type, reasoning "it was permitted in another material," is to misread the guide.
04Governing the unwritten domain by higher norms
The foreword made clear that the guide is a set of basic matters, not a complete enumeration, and that materials outside its provisions remain subject to the Pharmaceutical and Medical Device Act, the Standards for Fair Advertising, the guidelines for sales information provision activities, and the JPMA Code. When one meets a page that does not fit precisely into the three types of Part II, the answer is not "no provision, therefore free." Against the purpose of the advertisement — how far and in what way to convey the product's efficacy and safety — one returns to the spirit of the nearest type and to the higher norms to judge. The foreword's spirit of not turning a manual into an answer key becomes the operating rule here as well.
Part II handles the limited window of print journal advertising. By information volume it divides into ordinary, product-name, and editorial-style advertising; the more information, the more mandatory entries, and in the type that carries no information, "not carrying" is the discipline.
What stays constant is the core unchanged from Part I — the scope of approval, the honesty of data, the non-dropping of the mandatory. The constraint of a narrow page is not a reason to relax these, but works as a trial that sharpens priority. Confirm the detailed rules of each type one by one in the child pages.